BIOLASE has agreed to sell an aggregate of 14.16 million shares of its common stock at the price of $2.39 per share in a private placement transaction to the investors. In addition, the investors will receive warrants to purchase up to an aggregate of 9.2 million shares of BIOLASE common stock at an exercise price of $4 per share.
“We are pleased that our financial partners have expressed their confidence in our new strategy to deliver on the promise of laser dentistry and BIOLASE’s position as the industry leader through this investment. Our new experienced senior management team is already making progress in driving growth and innovation, and we are committed to growing BIOLASE and building shareholder value,” Jeffrey M. Nugent, president, CEO and a director of BIOLASE.
More articles on oral care:
Delta Dental of Michigan, Ohio, Indiana & New Mexico join private insurance exchange
12 dentist leadership moves
Wisconsin Office of Rural Health awards $15k to Ministry Door County Medical Center Dental Clinic
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
